Emphysema 2012
DOI: 10.5772/31744
|View full text |Cite
|
Sign up to set email alerts
|

Pathogenic Mechanisms in Emphysema: From Protease Anti-Protease Imbalance to Apoptosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2019
2019
2019
2019

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 101 publications
0
2
0
Order By: Relevance
“…Various types of lung disorders, such as the chronic obstructive lung disease, are known to be associated with protease/antiprotease imbalance (Abboud, 2012; Goopts et al, 2009). At present, the target proteases of Wfdc2 are unclear.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Various types of lung disorders, such as the chronic obstructive lung disease, are known to be associated with protease/antiprotease imbalance (Abboud, 2012; Goopts et al, 2009). At present, the target proteases of Wfdc2 are unclear.…”
Section: Discussionmentioning
confidence: 99%
“…In addition to mucins and surfactants, the epithelial cells of the lung secrete numerous proteases and protease inhibitors – such as serine proteases, matrix metalloproteinases (MMPs), serine protease inhibitors and tissue inhibitor of metalloproteinases (TIMPs) – that together form the protease/protease-inhibitor web (Löffek et al, 2011; Abboud, 2012; Meyer and Jaspers, 2015). These proteases and protease inhibitors are deeply involved in the pathophysiology of neonatal respiratory distress syndrome (RDS) as well as other lung diseases such as emphysema, cystic fibrosis, infection and pulmonary fibrosis (Meyer and Jaspers, 2015; Taggart et al, 2017).…”
Section: Introductionmentioning
confidence: 99%